Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research.

Su XW, Broach JR, Connor JR, Gerhard GS, Simmons Z.

Muscle Nerve. 2014 Jun;49(6):786-803. doi: 10.1002/mus.24198. Review.

PMID:
24488689
2.

Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing.

Kenna KP, McLaughlin RL, Byrne S, Elamin M, Heverin M, Kenny EM, Cormican P, Morris DW, Donaghy CG, Bradley DG, Hardiman O.

J Med Genet. 2013 Nov;50(11):776-83. doi: 10.1136/jmedgenet-2013-101795.

3.

Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system.

Liu ZJ, Li HF, Tan GH, Tao QQ, Ni W, Cheng XW, Xiong ZQ, Wu ZY.

Neurobiol Aging. 2014 Dec;35(12):2881.e11-5. doi: 10.1016/j.neurobiolaging.2014.07.003.

PMID:
25109764
4.

Evidence for an oligogenic basis of amyotrophic lateral sclerosis.

van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W, Medic J, Bourque PR, Schelhaas HJ, van der Kooi AJ, de Visser M, de Bakker PI, Veldink JH, van den Berg LH.

Hum Mol Genet. 2012 Sep 1;21(17):3776-84. doi: 10.1093/hmg/dds199.

5.

Novel FUS deletion in a patient with juvenile amyotrophic lateral sclerosis.

Belzil VV, Langlais JS, Daoud H, Dion PA, Brais B, Rouleau GA.

Arch Neurol. 2012 May;69(5):653-6.

PMID:
22248478
6.

Clinical highlights.

Borasio GD; Symposium on ALS/MND..

Amyotroph Lateral Scler. 2006 Dec;7(4):249-51. No abstract available.

PMID:
17127565
7.

Credibility analysis of putative disease-causing genes using bioinformatics.

Abel O, Powell JF, Andersen PM, Al-Chalabi A.

PLoS One. 2013 Jun 5;8(6):e64899. doi: 10.1371/journal.pone.0064899.

8.

Mutations in FUS are the most frequent genetic cause in juvenile sporadic ALS patients of Chinese origin.

Zou ZY, Liu MS, Li XG, Cui LY.

Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):249-52. doi: 10.3109/21678421.2016.1143012.

PMID:
26972116
9.

Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets.

Bosco DA, Landers JE.

CNS Neurol Disord Drug Targets. 2010 Dec;9(6):779-90. Review.

PMID:
20942785
10.

UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland.

McLaughlin RL, Kenna KP, Vajda A, Byrne S, Bradley DG, Hardiman O.

Neurobiol Aging. 2014 Jan;35(1):267.e9-11. doi: 10.1016/j.neurobiolaging.2013.07.023.

PMID:
23973441
11.

Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis.

Del Bo R, Tiloca C, Pensato V, Corrado L, Ratti A, Ticozzi N, Corti S, Castellotti B, Mazzini L, Sorarù G, Cereda C, D'Alfonso S, Gellera C, Comi GP, Silani V; SLAGEN Consortium..

J Neurol Neurosurg Psychiatry. 2011 Nov;82(11):1239-43. doi: 10.1136/jnnp.2011.242313.

PMID:
21613650
12.

Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis.

Takahashi Y, Seki N, Ishiura H, Mitsui J, Matsukawa T, Kishino A, Onodera O, Aoki M, Shimozawa N, Murayama S, Itoyama Y, Suzuki Y, Sobue G, Nishizawa M, Goto J, Tsuji S.

Arch Neurol. 2008 Oct;65(10):1326-32. doi: 10.1001/archneur.65.10.1326.

PMID:
18852346
13.

Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis.

Yang S, Fifita JA, Williams KL, Warraich ST, Pamphlett R, Nicholson GA, Blair IP.

Neurobiol Aging. 2013 Sep;34(9):2235.e7-10. doi: 10.1016/j.neurobiolaging.2013.04.003.

PMID:
23635659
14.

Exome sequencing reveals SPG11 mutations causing juvenile ALS.

Daoud H, Zhou S, Noreau A, Sabbagh M, Belzil V, Dionne-Laporte A, Tranchant C, Dion P, Rouleau GA.

Neurobiol Aging. 2012 Apr;33(4):839.e5-9. doi: 10.1016/j.neurobiolaging.2011.11.012.

PMID:
22154821
15.

Amyotrophic lateral sclerosis: Problems and prospects.

Sreedharan J, Brown RH Jr.

Ann Neurol. 2013 Sep;74(3):309-16. doi: 10.1002/ana.24012. Review.

PMID:
24038380
16.

Neuronal death in amyotrophic lateral sclerosis (ALS): what can we learn from genetics?

Sreedharan J.

CNS Neurol Disord Drug Targets. 2010 Jul;9(3):259-67. Review.

PMID:
20406185
17.

Expanding the genetics of amyotrophic lateral sclerosis and frontotemporal dementia.

Schymick JC, Traynor BJ.

Alzheimers Res Ther. 2012 Jul 26;4(4):30. doi: 10.1186/alzrt133. Review.

18.

The heterogeneity of amyotrophic lateral sclerosis: a possible explanation of treatment failure.

Beghi E, Mennini T, Bendotti C, Bigini P, Logroscino G, Chiò A, Hardiman O, Mitchell D, Swingler R, Traynor BJ, Al-Chalabi A.

Curr Med Chem. 2007;14(30):3185-200. Review.

PMID:
18220753
19.

Clinical and genetic heterogeneity of amyotrophic lateral sclerosis.

Sabatelli M, Conte A, Zollino M.

Clin Genet. 2013 May;83(5):408-16. doi: 10.1111/cge.12117. Review.

PMID:
23379621
20.

Genetics of familial amyotrophic lateral sclerosis.

Valdmanis PN, Rouleau GA.

Neurology. 2008 Jan 8;70(2):144-52. doi: 10.1212/01.wnl.0000296811.19811.db. Review.

PMID:
18180444
Items per page

Supplemental Content

Support Center